Compare CSTL & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | COUR |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.3M | 932.9M |
| IPO Year | 2019 | 2021 |
| Metric | CSTL | COUR |
|---|---|---|
| Price | $24.51 | $6.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $47.17 | $11.07 |
| AVG Volume (30 Days) | 261.5K | ★ 3.8M |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.22 |
| EPS | N/A | ★ N/A |
| Revenue | $344,229,000.00 | ★ $757,500,000.00 |
| Revenue This Year | $2.42 | $9.43 |
| Revenue Next Year | $12.69 | $6.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 3.66 | ★ 9.04 |
| 52 Week Low | $14.59 | $5.22 |
| 52 Week High | $44.28 | $13.56 |
| Indicator | CSTL | COUR |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 52.96 |
| Support Level | $21.77 | $5.48 |
| Resistance Level | $26.44 | $6.36 |
| Average True Range (ATR) | 1.14 | 0.33 |
| MACD | 0.24 | 0.02 |
| Stochastic Oscillator | 61.15 | 69.47 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.